Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Lab7 Systems Secures $3.0M Financing to Fuel Platform Growth and Commercial Expansion

    Oct 26, 2016, 14:31 PM by Michael Croft
    AUSTIN, TX - Oct 26, 2016 - Lab7 Systems, Inc., a leader in workflow management for data-intensive life science applications, announced today the closing of $3
    Full story
  • China National GeneBank Opening Hopes To Provide Resource For Global Health

    Oct 26, 2016, 10:20 AM by Michael Croft

    Bio-IT World Brief | The official opening of the China National GeneBank (CNGB) marks a new phase in Chinese-International genomics collaboration, providing scientists from across the world with access to one of the world's most comprehensive and sophisticated biorepositories with the goal of enabling breakthroughs in human health research, and contributing to global biodiversity conservation efforts.

    Full story
  • Digital Health Market: Converging Digital and Genomic Revolutions with Health and Society

    Oct 26, 2016, 03:52 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 26, 2016 - Digital health is technology-enabled care that involves the convergence of digital media, health technology, and mobile devices
    Full story
  • Solving The Lack Of Diversity In Genomic Research

    Oct 25, 2016, 16:55 PM by Michael Croft
    MIT Technology Review | An overwhelming majority of the data collected is from people of European ancestry. But researchers are trying to change that.
    Full story
  • Industry and Government Bodies Gather for Crucial Updates into Antibiotic Resistance in Just 3 Weeks at Superbugs USA 2016

    Oct 25, 2016, 15:56 PM by Michael Croft
    ISELIN, NJ, UNITED KINGDOM - Oct 26, 2016 - Just 3 weeks remain until SMi Group open its doors to host Superbugs & Superdrugs USA, the American instalment of its long running European conference
    Full story
  • Chinese Firm Admits Its Hacked Products Were Behind Friday's DDOS Attack

    Oct 25, 2016, 09:06 AM by Michael Croft
    Computerworld | A Chinese electronics component manufacturer says its products inadvertently played a role in a massive cyberattack that disrupted major internet sites in the U.S. on Friday.
    Full story
  • Antibody Drug Conjugates Market Driven by Extensive Research and Development Activities

    Oct 25, 2016, 06:59 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 25, 2016 - Antibody drug conjugates are monoclonal antibodies that are attached with biologically active drugs
    Full story
  • Pneumonia Diagnostics & Technologies Market – Evaluating New Diagnostic Technologies

    Oct 25, 2016, 03:55 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 25, 2016 - Pneumonia is a type of lung infection caused by microorganisms such as bacteria, virus, fungi and parasites
    Full story
  • UgenTec reaches milestone; acquires ISO 13485 certificate & CE-IVD label for artificially intelligent PCR interpretation software

    Oct 25, 2016, 03:39 AM by Michael Croft
    HASSELT, BELGIË - Oct 25, 2016 - UgenTec, the Belgian bioinformatics company that is developing universal & intelligent PCR analysis software, has received its ISO 13485 certification
    Full story
  • Creative Bioarray Enlarged Its Primary Cells Variety

    Oct 25, 2016, 00:21 AM by Michael Croft
    LONG ISLAND CITY, NY, UNITED STATES - Oct 24, 2016 - After transferred its core products line into cells, Creative Bioarray is endeavoring to enlarge its cells products variety to become a one-stop cells and related kits or tools supplier in USA, which doesn’t mean the company sold a narrow range of cells before the strategy launch
    Full story
  • Benchling Announces $7M in New Funding Led by Thrive Capital

    Oct 24, 2016, 13:04 PM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Oct 24, 2016 - Benchling, the next-generation life science R&D software company, announced that is has raised $7 million in new funding
    Full story
  • Research at MDI Biological Laboratory Examines Role of Early-Life Stress in Adult Illness

    Oct 24, 2016, 12:47 PM by Michael Croft
    BAR HARBOR, ME - Oct 24, 2016 - Scientists have long known that chronic exposure to psychosocial stress early in life can lead to an increased vulnerability later in life to diseases linked to immune dysfunction and chronic inflammation, including arthritis, asthma, cancer, diabetes, heart disease and even mental illness
    Full story
  • The Trials of Juno

    Oct 24, 2016, 09:28 AM by Michael Croft
    The Economist | Juno Therapeutics, a young biotech firm focused on cancer, promises both risk and reward with its attempt to master the T-cell. The firm is on the forefront of the most promising area of cancer treatments in decades.
    Full story
  • Cenduit Participates in QuintilesIMS Webinar to Share Tips on Continuous Glucose Monitoring (CGM) in Clinical Trials

    Oct 24, 2016, 09:07 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Oct 24, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is participating in a free webinar hosted by QuintilesIMS, where expert guest speakers will highlight regulatory trends, technology innovation and industry perspectives surrounding Continuous Glucose Monitoring (CGM) to help sponsors develop smarter diabetes clinical trials
    Full story
  • New Advance in Peptides Has Raised Increasing Attention

    Oct 24, 2016, 02:46 AM by Michael Croft
    SHIRLEY, NY - Oct 24, 2016 - As is known, it has long been a dream in medicine and pharmacy to use peptides as drugs. The driving force for such application is based on the ability of these compounds to improve the antibodies in the body
    Full story
  • Welcome to DNA.Land: Trait Prediction, A Breast Cancer Research Collaboration, And a Facebook Group

    Oct 21, 2016, 09:50 AM by Michael Croft

    Bio-IT World “We’ve already entered the era of ubiquitous genetic information.” says Yaniv Erlich, so he and colleagues have built DNA.Land, to crowdsource these available genomes from individuals. A ticker on the DNA.Land website counts almost 32,000 genomes deposited into DNA.Land so far. The project recently launched a collaboration with the National Breast Cancer Coalition and has started offering trait predictions. 

    Full story
  • Hydrolases Products Line Has Been Updated By Scientists in Creative Enzymes

    Oct 20, 2016, 23:44 PM by Michael Croft
    SHIRLEY, NY - Oct 21, 2016 - October 20, 2016, experienced scientists in Creative Enzymes introduced a part of newly-updated products belonging to hydrolases products, which symbolized the beginning of developing hydrolases products in Creative Enzymes
    Full story
  • Illumina Builds Africa GWAS Chip With H3Africa Initiative

    Oct 20, 2016, 13:45 PM by Michael Croft
    Bio-IT World | Last week, Illumina announced that it is creating an array for genome-wide association studies (GWAS) by the Human Heredity and Health in Africa (H3Africa) Initiative. The array—which isn’t available yet—will be include 2.5 million variations of specific interest to African populations.
    Full story
  • How Spinal Decompression Stops The Pain, Strengthens The Back And Restores Functional Use

    Oct 20, 2016, 13:38 PM by Michael Croft
    WILMINGTON, NC, UNITED STATES - Oct 20, 2016 - As mentioned earlier in this report, the procedure provides relief of pain and symptoms associated with herniated discs, bulging or protruding intervertebral discs, degenerative disc disease, sciatica and chronic pain
    Full story
  • Perlara Signs Rare Disease Pact with Novartis

    Oct 20, 2016, 10:48 AM by Michael Croft
    Chemical & Engineering News | In a critical validation for a biotech firm espousing an unusual business model, Perlara has struck a deal to develop lysosomal storage disorder treatments with Novartis. The big pharma company will also make an undisclosed investment in the rare-disease-focused firm.
    Full story
  • «
  • 341
  • 342
  • 343
  • 344 (current)
  • 345
  • 346
  • 347
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy